These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 16042543)
1. Disease modifying strategies for the treatment of Alzheimer's disease targeted at modulating levels of the beta-amyloid peptide. Pangalos MN; Jacobsen SJ; Reinhart PH Biochem Soc Trans; 2005 Aug; 33(Pt 4):553-8. PubMed ID: 16042543 [TBL] [Abstract][Full Text] [Related]
2. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease. Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398 [TBL] [Abstract][Full Text] [Related]
3. [Recent progress in the development of disease-modifying therapies for Alzheimer's disease]. Abe K Nihon Shinkei Seishin Yakurigaku Zasshi; 2010 Feb; 30(1):1-8. PubMed ID: 20297736 [TBL] [Abstract][Full Text] [Related]
4. Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo. Hussain I; Hawkins J; Harrison D; Hille C; Wayne G; Cutler L; Buck T; Walter D; Demont E; Howes C; Naylor A; Jeffrey P; Gonzalez MI; Dingwall C; Michel A; Redshaw S; Davis JB J Neurochem; 2007 Feb; 100(3):802-9. PubMed ID: 17156133 [TBL] [Abstract][Full Text] [Related]
5. [Therapy of Alzheimer disease]. Kovács T Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816 [TBL] [Abstract][Full Text] [Related]
6. The novel beta-secretase inhibitor KMI-429 reduces amyloid beta peptide production in amyloid precursor protein transgenic and wild-type mice. Asai M; Hattori C; Iwata N; Saido TC; Sasagawa N; Szabó B; Hashimoto Y; Maruyama K; Tanuma S; Kiso Y; Ishiura S J Neurochem; 2006 Jan; 96(2):533-40. PubMed ID: 16336629 [TBL] [Abstract][Full Text] [Related]
7. Expression and activity of beta-site amyloid precursor protein cleaving enzyme in Alzheimer's disease. Johnston JA; Liu WW; Todd SA; Coulson DT; Murphy S; Irvine GB; Passmore AP Biochem Soc Trans; 2005 Nov; 33(Pt 5):1096-100. PubMed ID: 16246054 [TBL] [Abstract][Full Text] [Related]
8. Amyloidogenic processing of beta-amyloid precursor protein in intracellular compartments. Vetrivel KS; Thinakaran G Neurology; 2006 Jan; 66(2 Suppl 1):S69-73. PubMed ID: 16432149 [TBL] [Abstract][Full Text] [Related]
9. The role of amyloid beta peptide 42 in Alzheimer's disease. Findeis MA Pharmacol Ther; 2007 Nov; 116(2):266-86. PubMed ID: 17716740 [TBL] [Abstract][Full Text] [Related]
10. Drugs targeting Alzheimer's disease: some things old and some things new. Michaelis ML J Pharmacol Exp Ther; 2003 Mar; 304(3):897-904. PubMed ID: 12604663 [TBL] [Abstract][Full Text] [Related]
11. Cholesterol and Alzheimer's disease--is there a relation? Sjögren M; Mielke M; Gustafson D; Zandi P; Skoog I Mech Ageing Dev; 2006 Feb; 127(2):138-47. PubMed ID: 16332384 [TBL] [Abstract][Full Text] [Related]